|
Re: Epigenetics market size
|
1
|
Zenith Epigenetics
|
Jan 22, 2024 02:46PM
|
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jan 30, 2024 02:24PM
|
|
Phase 1B in TNBC suspended
|
1
|
Zenith Epigenetics
|
May 23, 2024 07:18PM
|
|
Re: Zenith Royalties
|
1
|
Resverlogix Corp.
|
Jun 22, 2023 02:14PM
|
|
Re: Zenith trial partners
|
1
|
Zenith Epigenetics
|
Feb 01, 2023 01:13PM
|
|
Re: find it interesting that RVXCF.....
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 12:44PM
|
|
Re: Illiquid
|
2
|
Resverlogix Corp.
|
Dec 08, 2022 08:20PM
|
|
Re: Lu stepping down
|
2
|
Resverlogix Corp.
|
Feb 22, 2024 02:06PM
|
|
Re: find it interesting that RVXCF.....
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 01:55PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 22, 2024 12:07PM
|
|
Re: Toxicity
|
2
|
Zenith Epigenetics
|
Nov 02, 2022 03:53PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 03:49PM
|
|
Re: National Research Council's financially supported companies for COVID and LONG COVID
|
2
|
Resverlogix Corp.
|
Dec 09, 2022 01:37PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 07:55PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 23, 2024 12:13PM
|
|
Re: Your thoughts please
|
2
|
Resverlogix Corp.
|
Sep 09, 2024 11:53AM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 25, 2022 12:40PM
|
|
Re: debenture
|
2
|
Resverlogix Corp.
|
Mar 20, 2023 12:05PM
|
|
Re: Zenith Royalties
|
2
|
Resverlogix Corp.
|
Jun 27, 2023 05:10PM
|
|
Re: Another Week
|
2
|
Resverlogix Corp.
|
Oct 21, 2022 04:08PM
|
